Low Expression of p27 Protein Combined with Altered p53 and Rb/p16 Expression Status Is Associated with Increased Expression of Cyclin A and Cyclin B1 in Diffuse Large B-Cell Lymphomas
- 1 November 2001
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (11) , 1105-1113
- https://doi.org/10.1038/modpathol.3880444
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphomaLeukemia, 2000
- Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in b-cell non-Hodgkin's lymphomaInternational Journal of Cancer, 2000
- INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 GeneThe American Journal of Pathology, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- p27 in Cell Cycle Control and CancerLeukemia & Lymphoma, 2000
- Divergent Expression of Cclin-Dependent Kinase Inhibitors (CKI) And p14ARF/p16β in Non-Hodgkin's Lymphomas and Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2000
- Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphomaLeukemia, 1999
- CDK1 and Cyclin A Expression is Linked to Cell Proliferation and Associated with Prognosis in Non-Hodgkin's LymphomasLeukemia & Lymphoma, 1999
- Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor ProgressionThe American Journal of Pathology, 1998
- Investigation of the RB-1 Tumour Suppressor Gene in a United Kingdom Series of Non-Hodgkin's LymphomasLeukemia & Lymphoma, 1996